Business Punk Dossier, Issue 01\/21<\/p>\n
By autumn 2020 at the latest, the vaccine world will be looking to Mainz, to BioNTech. But it’s also worth taking a look at T\u00fcbingen and Neuried, at Prime Venture Technologies and Baseclick, who will also be looking for a coronavirus vaccine in spring 2020. How did it go for them?<\/p>\n
An excerpt:<\/strong><\/p>\n “Science is like sex. Sometimes something useful comes out of it, but that’s not why we do it,” American physicist Richard Feynman is said to have said. This pretty much sums up what the world of corona research has been experiencing over the past few months.<\/p>\n Following the outbreak of the coronavirus in early 2020, just about every research team in the world set out to develop a vaccine to prevent the spread of Covid-19. Since then, around 250 vaccine projects have been launched worldwide, with Prime Vector Technologies (PVT) in T\u00fcbingen and Baseclick in Neuried leading the way in Germany. Never heard of them? That’s probably because neither PVT nor Baseclick are among the fastest vaccine developers to make it into the press: Biontech. Moderna. AstraZeneca. But what about the ones that didn’t make it into our news tickers as push notifications?<\/p>\n","protected":false},"excerpt":{"rendered":" Business Punk Dossier, Issue 01\/21 By autumn 2020 at the latest, the vaccine world will be looking to Mainz, to BioNTech. But it’s also worth taking a look at T\u00fcbingen and Neuried, at Prime Venture Technologies and Baseclick, who will also be looking for a coronavirus vaccine in spring 2020. How did it go for […]<\/p>\n","protected":false},"author":2,"featured_media":2287,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"portfolio_category":[126],"class_list":["post-2575","portfolio","type-portfolio","status-publish","has-post-thumbnail","hentry","portfolio_category-feature-en"],"acf":[],"yoast_head":"\n